| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | |||||||||||||||||||||||||||||||||||||||||||||||||
| Q3-CY2026 | Q2-CY2026 | Q1-CY2026 | Q4-CY2025 | Q3-CY2025 | Q2-CY2025 | Q1-CY2025 | Q4-CY2024 | Q3-CY2024 | Q2-CY2024 | Q1-CY2024 | Q4-CY2023 | Q3-CY2023 | Q2-CY2023 | Q1-CY2023 | Q4-CY2022 | Q3-CY2022 | Q2-CY2022 | Q1-CY2022 | Q4-CY2021 | Q3-CY2021 | Q2-CY2021 | Q1-CY2021 | Q4-CY2020 | Q3-CY2020 | Q2-CY2020 | Q1-CY2020 | Q4-CY2019 | Q3-CY2019 | Q2-CY2019 | Q1-CY2019 | Q4-CY2018 | Q3-CY2018 | Q2-CY2018 | Q1-CY2018 | Q4-CY2017 | Q3-CY2017 | Q2-CY2017 | Q1-CY2017 | Q4-CY2016 | Q3-CY2016 | Q2-CY2016 | Q1-CY2016 | Q4-CY2015 | Q3-CY2015 | Q2-CY2015 | Q1-CY2015 | Q4-CY2014 | Q3-CY2014 | |
| Balance Sheet Date | 2026-Apr-30 | 2026-Jan-31 | 2025-Oct-31 | 2025-Jul-31 | 2025-Apr-30 | 2025-Jan-31 | |||||||||||||||||||||||||||||||||||||||||||
| Fiscal Period | Q4-FY2026 | Q3-FY2026 | Q2-FY2026 | Q1-FY2026 | Q4-FY2025 | Q3-FY2025 | |||||||||||||||||||||||||||||||||||||||||||
| Price to Sales | 14.97x | 15.62x | 12.21x | 18.49x | 16.45x | 12.91x | |||||||||||||||||||||||||||||||||||||||||||
| Price to Book | 5.48x | 5.72x | 4.47x | 5.38x | 7.44x | 4.65x | |||||||||||||||||||||||||||||||||||||||||||
| Price to Earnings | - | - | - | - | - | - | |||||||||||||||||||||||||||||||||||||||||||
| Price to Unlevered FCF | - | - | - | - | - | - | |||||||||||||||||||||||||||||||||||||||||||
| Debt to Asset Ratio | .28x | .24x | .33x | .31x | .31x | 1.70x | |||||||||||||||||||||||||||||||||||||||||||
| Current Ratio | 4.41x | 7.32x | 5.47x | 6.84x | 6.72x | .45x | |||||||||||||||||||||||||||||||||||||||||||